Body defense potential was examined in 156 patients with genital fistulas of inflammatory origin. Addition of myelopid, an immunomodulating agent, to the scheme of preoperative treatment was experimentally validated. Preoperative preparation was assessed from the time course of the patients' general status, blood parameters, liver and kidney functions, and immunity status.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!